United Derm Partners

The firm does not publicly name its investment committee or CEO. As a private platform company with no website or regulatory filings available, leadership details are not confirmed. To evaluate management, potential partners would need to engage directly with the firm.

The firm likely sources deals through direct outreach to independent dermatology practices, industry conferences, and physician referrals. Without public disclosures, the precise sourcing model is unknown. Competing platforms typically use a combination of broker networks and direct physician relationships.

United Derm Partners appears to operate as a private equity-backed platform company, not a family office or venture firm. It makes majority investments in dermatology practices, a model typical of healthcare roll-up funds. The underlying capital source is not publicly disclosed.

The firm executes direct acquisitions of dermatology practices. There is no evidence it makes fund commitments or operates as a fund-of-funds. Its model involves buying and integrating operating businesses, not investing in third-party funds.

United Derm Partners focuses on mature, independent dermatology practices, not early-stage startups. The typical deal is a majority buyout of an established clinic. Growth investments may follow to expand services or open new locations.

By name and location, the firm concentrates exclusively on dermatology. It likely avoids primary care, multi-specialty groups, and hospital systems. Its narrow vertical focus distinguishes it from broader physician practice consolidators.

No parent company, sponsor, or related vehicle is publicly identified. The firm may be backed by a private equity group, but that relationship is not confirmed. Without disclosure, the capital structure is opaque.